Change language
English Deutsch
Change currency
€ EUR £ GBP $ USD
Licensed Unlicensed Requires Authentication Published by De Gruyter June 1, 1990

BEHAVIOURAL PHARMACOLOGY OF THE SERENIC, ELTOPRAZINE

  • B. Olivier, , J. Mos, and D.L. Rasmussen,
From the journal Drug Metabolism and Drug Interactions
https://doi.org/10.1515/DMDI.1990.8.1-2.31
Published Online: 1990-06

©2011 by Walter de Gruyter GmbH & Co.

From the journal
Drug Metabolism and Drug Interactions
Drug Metabolism and Drug Interactions
Volume 8 Issue 1-2
Submit manuscript

Journal and Issue

Articles in the same Issue

TABLE OF CONTENTS
SERENICS: AN INTRODUCTION
ETHOPHARMACOLOGY: A CREATIVE APPROACH TO IDENTIFICATION AND CHARACTERISATION OF NOVEL PSYCHOTROPICS
BEHAVIOURAL PHARMACOLOGY OF THE SERENIC, ELTOPRAZINE
NEUROCHEMICAL PROFILE OF ELTOPRAZINE
DISTRIBUTION OF RADIOACTIVELY LABELLED ELTOPRAZINE IN RAT AND DOG
THE METABOLITE PATTERNS OF ELTOPRAZINE IN MAN, DOG, RAT AND RABBIT
PHARMACOKINETICS OF ELTOPRAZINE IN THE DOG
PHARMACOKINETICS OF ELTOPRAZINE IN HEALTHY SUBJECTS
POSSIBLE CLINICAL APPLICATIONS OF SERENICS AND SOME IMPLICATIONS OF THEIR PRECLINICAL PROFILE FOR THEIR CLINICAL USE IN PSYCHIATRIC DISORDERS
Downloaded on 18.5.2024 from https://www.degruyter.com/document/doi/10.1515/DMDI.1990.8.1-2.31/html
Scroll to top button